-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Leap Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for Q3 2024.
- Leap Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $708K.
- Leap Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $147K.
- Leap Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$24K, a 1100% decline from 2020.
- Leap Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was -$2K, a 33.3% increase from 2019.
Income Tax Expense (Benefit), Quarterly (USD)